Peripheral Mononuclear Cell Mitochondrial Function Associates with T‐Cell Cytokines in Parkinson's Disease
Movement Disorders · 2025-08 · 40 (8) · 1625-1635
DOI: 10.1002/mds.30233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 16.05.2025. Verfasst von Fatima Afaar und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Parkinson Disease, Mitochondria, Cytokines, Leukocytes, Mononuclear. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Parkinson's Mission.
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is the most common neurodegenerative movement disorder and one of the world's fastest‐growing neurological diseases. Although the exact causes of PD are unknown, mitochondrial dysfunction and inflammation may have significant roles in disease progression. As well as being prevalent in the brain, there is also evidence that peripheral mitochondrial dysfunction and inflammation occur in PD. However, if/how peripheral mitochondrial dysfunction and inflammation are linked is still unclear.
Objectives
This study aimed to determine the extent that mitochondrial dysfunction in peripheral immune cells is associated with inflammation in PD.
Methods
The study comprised of 35 controls and 35 PD patients that were age and sex matched. Flow cytometry was used to assess mitochondrial content and superoxide production in mononuclear cells, in the presence and absence of the mitochondrial stressor antimycin A. Serum inflammatory cytokines were measured by ELISA.
Results
Superoxide levels were significantly increased in PD patient mononuclear cells at baseline, and PD mononuclear cells had an impaired response to antimycin A. Immune cell superoxide levels correlated with serum cytokines associated with T‐cell responses, namely interleukin (IL) IL‐12, interferon‐γ, and IL‐17A.
Conclusions
Results show that mitochondrial dysfunction is prevalent in PD immune cells and may contribute to an inflammatory phenotype. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, Australia.
- Parkinson's Disease Research Clinic, Macquarie Medical School, Macquarie University, Sydney, Australia.
ORCID-Profile: Glenda M Halliday, Nicolas Dzamko
Förderung
- Australian Parkinson's Mission
Zitieren
APA
Afaar, F., Youssef, P., Galper, J., Chua, M., Halliday, G. M., Lewis, S. J. G., & Dzamko, N. (2025). Peripheral Mononuclear Cell Mitochondrial Function Associates with T‐Cell Cytokines in Parkinson's Disease. Movement Disorders, 40(8), 1625-1635. https://doi.org/10.1002/mds.30233
Vancouver
Afaar F, Youssef P, Galper J, Chua M, Halliday GM, Lewis SJG, et al. Peripheral Mononuclear Cell Mitochondrial Function Associates with T‐Cell Cytokines in Parkinson's Disease. Movement Disorders. 2025;40(8):1625-1635. doi:10.1002/mds.30233
BibTeX
@article{Afaar2025,
author = {Afaar, Fatima and Youssef, Priscilla and Galper, Jasmin and Chua, Michelle and Halliday, Glenda M and Lewis, Simon J G and Dzamko, Nicolas},
title = {Peripheral Mononuclear Cell Mitochondrial Function Associates with T‐Cell Cytokines in Parkinson's Disease},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {8},
pages = {1625--1635},
doi = {10.1002/mds.30233}
}
EUVIMED